Review article: proton pump inhibitors and bacterial overgrowth

C. Williams, K. E. L. McColl

Research output: Contribution to journalArticle

Abstract

Proton pump inhibitors are potent drugs producing profound suppression of gastric acid secretion. Consequently, they are highly effective at treating acid-related disorders. There have been concerns that the suppression of gastric acid will alter the bacterial flora of the upper gastrointestinal tract and lead to complications such as cancer, enteric or other infections and malabsorption. Studies have confirmed that proton pump inhibitors do alter the bacterial population but present evidence indicates that this only rarely leads to clinical disease. As with all drugs, proton pump inhibitors should only be used for disorders shown clearly to benefit from the therapy and where the benefits will outweigh the small risks associated with them. Further research to more fully quantify the risk associated with PPI therapy is required.

Original languageEnglish
Pages (from-to)3-10
Number of pages8
JournalAlimentary Pharmacology & Therapeutics
Volume23
Issue number1
DOIs
Publication statusPublished - 1 Jan 2006
Externally publishedYes

Fingerprint

Proton Pump Inhibitors
Gastric Acid
Upper Gastrointestinal Tract
Pharmaceutical Preparations
Acids
Therapeutics
Infection
Research
Population
Neoplasms

Keywords

  • Achlorhydria
  • Anti-Ulcer Agents
  • Bacterial Infections
  • Gastric Acid
  • Gastrointestinal Diseases
  • Humans
  • Nitrites
  • Proton Pump Inhibitors
  • Upper Gastrointestinal Tract
  • Journal Article
  • Review

Cite this

@article{e6ead2e67ee34d139abca9672b6d4de9,
title = "Review article: proton pump inhibitors and bacterial overgrowth",
abstract = "Proton pump inhibitors are potent drugs producing profound suppression of gastric acid secretion. Consequently, they are highly effective at treating acid-related disorders. There have been concerns that the suppression of gastric acid will alter the bacterial flora of the upper gastrointestinal tract and lead to complications such as cancer, enteric or other infections and malabsorption. Studies have confirmed that proton pump inhibitors do alter the bacterial population but present evidence indicates that this only rarely leads to clinical disease. As with all drugs, proton pump inhibitors should only be used for disorders shown clearly to benefit from the therapy and where the benefits will outweigh the small risks associated with them. Further research to more fully quantify the risk associated with PPI therapy is required.",
keywords = "Achlorhydria, Anti-Ulcer Agents, Bacterial Infections, Gastric Acid, Gastrointestinal Diseases, Humans, Nitrites, Proton Pump Inhibitors, Upper Gastrointestinal Tract, Journal Article, Review",
author = "C. Williams and McColl, {K. E. L.}",
year = "2006",
month = "1",
day = "1",
doi = "10.1111/j.1365-2036.2006.02707.x",
language = "English",
volume = "23",
pages = "3--10",
journal = "Alimentary Pharmacology & Therapeutics",
issn = "0269-2813",
publisher = "Wiley",
number = "1",

}

Review article : proton pump inhibitors and bacterial overgrowth. / Williams, C.; McColl, K. E. L.

In: Alimentary Pharmacology & Therapeutics, Vol. 23, No. 1, 01.01.2006, p. 3-10.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Review article

T2 - proton pump inhibitors and bacterial overgrowth

AU - Williams, C.

AU - McColl, K. E. L.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Proton pump inhibitors are potent drugs producing profound suppression of gastric acid secretion. Consequently, they are highly effective at treating acid-related disorders. There have been concerns that the suppression of gastric acid will alter the bacterial flora of the upper gastrointestinal tract and lead to complications such as cancer, enteric or other infections and malabsorption. Studies have confirmed that proton pump inhibitors do alter the bacterial population but present evidence indicates that this only rarely leads to clinical disease. As with all drugs, proton pump inhibitors should only be used for disorders shown clearly to benefit from the therapy and where the benefits will outweigh the small risks associated with them. Further research to more fully quantify the risk associated with PPI therapy is required.

AB - Proton pump inhibitors are potent drugs producing profound suppression of gastric acid secretion. Consequently, they are highly effective at treating acid-related disorders. There have been concerns that the suppression of gastric acid will alter the bacterial flora of the upper gastrointestinal tract and lead to complications such as cancer, enteric or other infections and malabsorption. Studies have confirmed that proton pump inhibitors do alter the bacterial population but present evidence indicates that this only rarely leads to clinical disease. As with all drugs, proton pump inhibitors should only be used for disorders shown clearly to benefit from the therapy and where the benefits will outweigh the small risks associated with them. Further research to more fully quantify the risk associated with PPI therapy is required.

KW - Achlorhydria

KW - Anti-Ulcer Agents

KW - Bacterial Infections

KW - Gastric Acid

KW - Gastrointestinal Diseases

KW - Humans

KW - Nitrites

KW - Proton Pump Inhibitors

KW - Upper Gastrointestinal Tract

KW - Journal Article

KW - Review

U2 - 10.1111/j.1365-2036.2006.02707.x

DO - 10.1111/j.1365-2036.2006.02707.x

M3 - Article

VL - 23

SP - 3

EP - 10

JO - Alimentary Pharmacology & Therapeutics

JF - Alimentary Pharmacology & Therapeutics

SN - 0269-2813

IS - 1

ER -